Isoflavone und Soja haben keine Wirkung auf die Knochendichte

P . b . b . G Z 0 2 Z 0 3 1 1 0 8 M , V e r l a g s p o s t a m t : 3 0 0 2 P u r k e r s d o r f , E r s c h e i n u n g s o r t : 3 0 0 3 G a b l i t z Indexed in SCOPUS/EMBASE/Excerpta Medica www.kup.at/mineralstoffwechsel Österreichische Gesellschaft für Orthopädie und Orthopädische Chirurgie Österreichische Gesellschaft für Rheumatologie Offizielles Organ der Österreichischen Gesellschaft zur Erforschung des Knochens und Mineralstoffwechsels Member of the Isovlavone und Soja haben keine

[1]  J. Krischer,et al.  Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. , 2011, Archives of internal medicine.

[2]  Y. Ishimi,et al.  Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial , 2011, Menopause.

[3]  Antonia C Hardcastle,et al.  Associations between dietary flavonoid intakes and bone health in a scottish population , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  C. Castelo-Branco,et al.  Isoflavones: effects on bone health , 2011, Climacteric : the journal of the International Menopause Society.

[5]  S. Barnes,et al.  Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. , 2011, The American journal of clinical nutrition.

[6]  S. Levis,et al.  Phytoestrogens and bone health , 2010, Current opinion in endocrinology, diabetes, and obesity.

[7]  F. Parazzini,et al.  Soy isoflavones and bone mineral density in perimenopausal and postmenopausal Western women: a systematic review and meta-analysis of randomized controlled trials. , 2010, Journal of women's health.

[8]  Y. Ishimi,et al.  Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials. , 2010, Bone.

[9]  C. Weaver,et al.  Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone loss. , 2010, The Journal of nutrition.

[10]  S. Barnes,et al.  Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial. , 2009, The American journal of clinical nutrition.

[11]  S. Ho,et al.  Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials. , 2009, Bone.

[12]  J. Lampe.  Is equol the key to the efficacy of soy foods? , 2009, The American journal of clinical nutrition.

[13]  M. Kleerekoper,et al.  Soy isoflavones in the management of postmenopausal osteoporosis , 2008, Menopause.

[14]  F. Branca,et al.  Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. , 2008, The American journal of clinical nutrition.

[15]  Y. Ishimi,et al.  Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial , 2007, Menopause.

[16]  K. Setchell,et al.  S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. , 2005, The American journal of clinical nutrition.

[17]  K. Setchell,et al.  Soymilk or progesterone for prevention of bone loss , 2004, European journal of nutrition.

[18]  S. Ho,et al.  Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. , 2003, The Journal of clinical endocrinology and metabolism.

[19]  S. Inoue,et al.  Interaction of Phytoestrogens with Estrogen Receptors α and β , 2001 .

[20]  C. Christiansen,et al.  Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. , 2001, JAMA.

[21]  Daniel J. Schiferl,et al.  The soy isoflavones for reducing bone loss study: 3-yr effects on pQCT bone mineral density and strength measures in postmenopausal women. , 2011, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[22]  K. Koehler,et al.  The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women. , 2010, The American journal of clinical nutrition.

[23]  S. Inoue,et al.  Interaction of phytoestrogens with estrogen receptors alpha and beta. , 2001, Biological & pharmaceutical bulletin.